Goldman Sachs’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.6M | Sell |
|
|||||
|
2025
Q2 | $10.6M | Sell |
|
|||||
|
2025
Q1 | $15.3M | Buy |
|
|||||
|
2024
Q4 | $5.39M | Buy |
|
|||||
|
2024
Q3 | $2.38M | Buy |
|
|||||
|
2024
Q2 | $710K | Buy |
|
|||||
|
2024
Q1 | $556K | Sell |
|
|||||
|
2023
Q4 | $608K | Buy |
|
|||||
|
2023
Q3 | $247K | Sell |
|
|||||
|
2023
Q2 | $587K | Buy |
|
|||||
|
2023
Q1 | $203K | Sell |
|
|||||
|
2022
Q4 | $218K | Buy |
|
|||||
|
2022
Q3 | $191K | Buy |
|
|||||
|
2022
Q2 | $173K | Sell |
|
|||||
|
2022
Q1 | $1.86M | Buy |
|
|||||
|
2021
Q4 | $667K | Buy |
|
|||||
|
2021
Q3 | $305K | Buy |
|
|||||
|
2021
Q2 | $399K | Buy |
|
|||||
|
2021
Q1 | $388K | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $464K | Sell |
|
|||||
|
2020
Q2 | $427K | Buy |
|
|||||
|
2020
Q1 | $237K | Buy |
|
|||||
|
2019
Q4 | $132K | Sell |
|
|||||
|
2019
Q3 | $295K | Buy |
|
|||||
|
2019
Q2 | $197K | Sell |
|
|||||
|
2019
Q1 | $427K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $541K | Buy |
|